CAS 1173976-40-3

Gefitinib-d3

Produit contrôlé

CAS : 1173976-40-3

Applications Labelled Gefitinib (G304000). Gefitinib is an antineoplastic.
References Anderson, N.G., et al.: Int. J. Cancer, 94, 774 (2001), Hirata, A., et al.: Cancer Res., 62, 2554 (2002), Kris, M.G., et al.: J. Am. Med. Assoc., 290, 2149 (2003), Tamura, K., et al.: Expert Opin. Pharmacother., 6, 985 (2005),

Formule : C₂₂H₂₁D₃ClFN₄O₃

Couleur et forme : Neat

Masse moléculaire : 449.92

Ref: TR-G304002

Gefitinib-d3

CAS : 1173976-40-3

Gefitinib-d3 is a potent inhibitor of the protein kinase activity of the epidermal growth factor receptor (EGFR). It is used in medicinal chemistry research to study the mechanisms of apoptosis and cell cycle regulation. Gefitinib-d3 inhibits cyclin-dependent kinases, which play a key role in tumor growth and proliferation. This drug has been shown to be effective against several types of human cancer, including leukemia, lung cancer, and breast cancer. It works by blocking the signals that stimulate cell growth and division, leading to the death of cancer cells. Gefitinib-d3 is an important tool for researchers studying the molecular mechanisms underlying cancer development and progression.

Formule : C₂₂H₂₄ClFN₄O₃

Degré de pureté : Min. 95%

Masse moléculaire : 449.9 g/mol

Ref: 3D-YWB97640